From Eli Lilly to Karuna Therapeutics to current owner Bristol Myers Squibb, the newly approved schizophrenia drug had quite ...

Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach.

The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in ...

Essential oils like peppermint, rosemary, and lavender may enhance memory and cognitive function in older adults.

A 16-year-old girl came to the emergency room for leg pain that had started in her calves about 24 hours earlier and then spread throughout her legs. She felt so weak, she could not walk without ...

Affiliate content. Compare Nerve Recovery and Nerve Fresh to find out which supplement is the better choice for nerve health.

But Bristol Myers Squibb's new drug will indirectly target the dopamine receptors by targeting the neurochemical ...

Anticholinergic drugs work by blocking the action of a neurotransmitter called acetylcholine. Acetylcholine is responsible for transferring signals between certain cells that affect specific bodily ...

Dianthus Therapeutics' DNTH103 is in phase 2 trials for gMG, CIDP, and MMN, offering a differentiated, convenient dosing ...

It is crucial to note that the effectiveness of nootropics varies, and not all have significant clinical evidence backing ...

An international team of researchers and gamers, led by Princeton’s Mala Murthy and Sebastian Seung, mapped every neuron and ...